US approval this Week = 200% Potential !!!!!

[BiotechMaster]

Get in now before its too late !!!!

Cytomedix (AMEX : GTF )

Market Cap : 18,8 Mio$
Price : 0,50 $

Shares Out : 37,3 M

On August 7, 2009, Cytomedix, Inc. (NYSE AMEX:GTF) announced that it has submitted to, the United Sates of America’s toughest regulator, the Food and Drug Administration (FDA) a 510(K) for its AutoloGel™ Platelet Separation System. The 510(K) submission was made to obtain pre market approval from the FDA. We anticipate they will get a response from the FDA after 6 months, i.e. on or around February 7, 2010. However, the FDA may not give its decision on this date and there is no way to find out when it will, since the FDA is not bound by law to notify about decision dates for any submission, such as 510(K), related to medical devices.

[globalequitygroup]

Approval will likely not occur on this stock this week due to the weather in DC.

However, I would like to know why you think there is 200% profit potential in this stock upon approval.

[pollo]

look is a good cange !! price 1.23

next week 2.00 minimo

[Austinstars]

Approval will likely not occur on this stock this week due to the weather in DC.

However, I would like to know why you think there is 200% profit potential in this stock upon approval.

I Googled the company's history and found a good link that supports a strong future for the company after blazing a rough trail. They have protected their patent and formed aliances that will help distribute/sell their product. The marketing time will be substantial in this industry but the ground work is being laid. 200% stock market price gain, who knows how long that will take but I believe, given the recent FDA approval they will get there. See some history here, but Google the symbol for plenty of supporting information. findarticles.com/p/articles/mi_hb5248/is_27_22/ai_n29195364/pg_2/?tag=content;col1


Cytomedix Inc. Regroups East, leaves state - page 2 | Arkansas Business